Policy & Practice

View the latest content related to this topic

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Even with recommendations in place, hospitals were far from uniform in their anticoagulation approaches well into 2022.

L.A. McKeown

March 06, 2025

Slides

See all

Presentation CTO 2025

Lessons from My First Year(s) in Practice

Presenter: Laura Young

February 28, 2025

Presentation CTO 2025

Lessons from My First Year(s) in Practice

Presenter: Pratik Sandesara

February 28, 2025

Presentation CTO 2025

Lessons from My First Year(s) in Practice

Presenter: Bryan Kindya

February 28, 2025

Presentation Controversies and Advances 2025

The role of double-blind sham-controlled trials in interventional cardiology

Presenter: Rasha Al-Lamee

January 31, 2025

Presentation Controversies and Advances 2025

The Good, the Bad and the Ugly of Clinical Trial Design

Presenter: Stuart Pocock

January 31, 2025

News

See all

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

By Michael O'Riordan

March 13, 2025

News Daily News

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

By Yael L. Maxwell

March 13, 2025

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

By L.A. McKeown

March 12, 2025

News Daily News

Food Insecurity in Adulthood Signals Greater Risk of Later CVD

By Todd Neale

March 12, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

By Michael O'Riordan

March 11, 2025

AHA 2024

November 16

November 18, 2024

TCT 2024

October 27

October 30, 2024

ESC Congress 2024

August 30

September 02, 2024

Videos on This Topic

See all

Advertisement

Policy & Practice

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Slides

Lessons from My First Year(s) in Practice

Lessons from My First Year(s) in Practice

Lessons from My First Year(s) in Practice

The role of double-blind sham-controlled trials in interventional cardiology

The Good, the Bad and the Ugly of Clinical Trial Design

News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

Food Insecurity in Adulthood Signals Greater Risk of Later CVD

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

More on This Topic

Conference Coverage

AHA 2024

TCT 2024

ESC Congress 2024

Videos on This Topic

Advertisement

Policy & Practice

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content